Natural killer T cells as targets for immunotherapy of autoimmune diseases.
about
Peripheral blood but not synovial fluid natural killer T cells are biased towards a Th1-like phenotype in rheumatoid arthritisIntravital imaging - dynamic insights into natural killer T cell biologyCellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistanceModulation of NKT cell development by B7-CD28 interaction: an expanding horizon for costimulation.Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice.T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to alpha-galactosylceramide are impaired.Fluid-phase chain unsaturation controlling domain microstructure and phase in ternary lipid bilayers containing GalCer and cholesterolBeta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disordersCharacterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis.Bystander activation of iNKT cells occurs during conventional T-cell alloresponsesThe structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis.Brief treatment with iNKT cell ligand α-galactosylceramide confers a long-term protection against lupus.Structural and Functional Changes of the Invariant NKT Clonal Repertoire in Early Rheumatoid Arthritis.Glycolipids as immunostimulating agents.The natural killer T cell ligand alpha-galactosylceramide prevents or promotes pristane-induced lupus in miceImpact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice.Parasites and immunotherapy: with or against?beta-Glycosphingolipids as immune modulators.Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administration.Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptorNK cell autoreactivity and autoimmune diseases.Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?The liver works as a school to educate regulatory immune cells.Current advances in understanding of immunopathology of atherosclerosis.Endogenous collagen peptide activation of CD1d-restricted NKT cells ameliorates tissue-specific inflammation in miceWhat rheumatologists need to know about innate lymphocytes.Generation of antibody responses to pneumococcal capsular polysaccharides is independent of CD1 expression in mice.The requirement of natural killer T-cells in tolerogenic APCs-mediated suppression of collagen-induced arthritis.Natural killer T-cell characterization through gene expression profiling: an account of versatility bridging T helper type 1 (Th1), Th2 and Th17 immune responses.
P2860
Q24816601-B408F6BB-8BAB-45F5-B899-100611F4426CQ28081530-8D96D397-6052-411C-95C9-26C99F88BE3CQ30009848-8B257773-6E3E-4CB0-8FEF-D69219B47F34Q30845162-AB1405A0-AC7C-473B-B524-74AE70AB134BQ35043531-5E2D508A-0F55-48AA-B799-ABABDB87BBBFQ35050030-89904EC9-2368-428D-92B5-5E329C50DF8DQ35696533-A290A8BE-B374-43A7-89D9-1BE158B31548Q35761273-4ED10053-9935-4ACC-85FD-746EA6188BCBQ35781343-6EB9C8B0-4191-4090-ACCE-E9E386947A59Q35890019-1E949BE8-397D-4DDE-B499-63F4F674D41BQ36027486-00F97CEA-D168-4B3D-95FD-71B915A29458Q36203872-DB6C016D-4585-4A13-8E83-72E0A80E15B5Q36351033-65631551-5C39-4E35-9E86-8CA2BDA2676CQ36517889-C7C6B006-7A3D-4BE3-9EAC-22F7BBE369F6Q36536904-5B06CC72-F350-4EB6-AFFE-61A7200B9A1AQ36597496-E9F38F52-E184-427D-8E41-9C68EDDF896DQ37053248-2D34AAF0-2816-4903-B981-9BD25896F09AQ37196707-52986E24-4111-4EC5-89F3-6F5C8831D241Q37237496-F93478FF-2514-4367-8CF9-4DFA775A728AQ37297950-F3E7B2C9-DC25-445F-8A3B-E97796AE4592Q37552129-1D0476C4-AFD2-4171-8B29-8C9A0D012340Q37582663-C98CAEFA-4BF6-40E1-8133-0A821167E240Q37729659-9F6D17F7-BA97-4971-AB67-CBA601D2862FQ37808645-EF2ACE11-10F1-48AC-B9D0-08728B870251Q38338690-53A29696-A544-45C3-BD15-AD8BF2234F77Q38809547-3B9B1D83-2B44-4092-9B01-0782AF56F80AQ42025073-F0DA6134-0D57-464B-804E-91E8CDAB9AECQ42275756-3820ADC2-7AB4-4C3F-B152-00053C9526CBQ52922958-7A486444-B23F-41A7-8F87-407AF255B4B3
P2860
Natural killer T cells as targets for immunotherapy of autoimmune diseases.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Natural killer T cells as targets for immunotherapy of autoimmune diseases.
@ast
Natural killer T cells as targets for immunotherapy of autoimmune diseases.
@en
type
label
Natural killer T cells as targets for immunotherapy of autoimmune diseases.
@ast
Natural killer T cells as targets for immunotherapy of autoimmune diseases.
@en
prefLabel
Natural killer T cells as targets for immunotherapy of autoimmune diseases.
@ast
Natural killer T cells as targets for immunotherapy of autoimmune diseases.
@en
P2860
P1476
Natural killer T cells as targets for immunotherapy of autoimmune diseases.
@en
P2860
P304
P356
10.1111/J.0818-9641.2004.01252.X
P50
P577
2004-06-01T00:00:00Z